Table 5.
Sensitivity and specificity of re-weighted CHA2DS2-VASc and HAS–BLED scales with the addition of MoCA, SPPB, and GDS in relation to the three neuroimaging outcomes.
| CMBs | Lacunar Infarcts | Non-Lacunar Infarcts | ||||
|---|---|---|---|---|---|---|
| CHA2DS2-VASc | HAS–BLED | CHA2DS2-VASc | HAS–BLED | CHA2DS2-VASc | HAS–BLED | |
| Sensitivity | 0.6739 | 0.239 | 0.7407 | 0.5185 | 0.6981 | 0.6415 |
| Specificity | 0.6371 | 0.8952 | 0.6121 | 0.8103 | 0.8547 | 0.8974 |